The objective of this study is to investigate whether percutaneous PFO closure with the Occlutech Flex II PFO Occluder is non-inferior to the AMPLATZER™ PFO Occluder and Gore® Cardioform Septal Occluder in closure of the PFO, prevention of recurrent embolic stroke, and device/procedure related Serious Adverse Events (SAE)
Patient Stories
June 21, 2022
Maureen Ducharme knew that she couldn't put off the procedure any longer. In 2009, Ducharme, 55, from Springfield, suffered two strokes within a couple of weeks.